Novel oncoprotein EPS8: a new target for anticancer therapy.
about
Actin binding proteins in blood-testis barrier functionActin binding proteins, spermatid transport and spermiationIdentification of human leukemia antigen A*0201-restricted epitopes derived from epidermal growth factor pathway substrate number 8A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model.Re-positioning protein-kinase inhibitors against schistosomiasis.Generation of cytotoxic T lymphocytes specific for native or modified peptides derived from the epidermal growth factor receptor pathway substrate 8 antigen.EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8.A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia.
P2860
Q27000752-BFC7D6A0-237B-43E3-B915-DFC999977619Q27001537-3628582A-1B5C-4FD1-9622-37546ACCDD41Q35724710-D0C5B972-4E82-4F43-8D98-31BB2635785CQ37362844-41D827D4-452D-4D42-81D9-12CB21C6E8DFQ38495042-9AADC992-44CD-48F5-B89A-593CF7706F40Q38942201-826B7378-350F-4414-B5D4-4DBACAAFD14BQ47388144-254139CF-DA93-4CA2-A312-FB24263A9719Q48220908-EFFE7A1E-1814-4867-88B5-337465FBCDA7Q49556327-2D666A18-DAB5-4735-85AA-1ED31F83A560
P2860
Novel oncoprotein EPS8: a new target for anticancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel oncoprotein EPS8: a new target for anticancer therapy.
@en
type
label
Novel oncoprotein EPS8: a new target for anticancer therapy.
@en
prefLabel
Novel oncoprotein EPS8: a new target for anticancer therapy.
@en
P2093
P2860
P356
P1433
P1476
Novel oncoprotein EPS8: a new target for anticancer therapy.
@en
P2093
Jing-Wen Du
Tong-Yuan Xue
Ying-Zhi He
P2860
P304
P356
10.2217/FON.13.104
P407
P577
2013-10-01T00:00:00Z